All In Biotech

Investigational drug · Phase 2

Icalcaprant

Also called: ABBV-1354, CVL-354

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Bipolar I Disorder, Bipolar II Disorder, Major Depressive Disorder.

Phase 2

Last checked: Nov 19, 2026Latest source record: Aug 14, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

2

2 still active

All registered trials

5

Any phase or sponsor naming "Icalcaprant"

First trial start

2025

Dec 18, 2025

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Icalcaprant", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Bipolar I Disorder
  • Bipolar II Disorder
  • Major Depressive Disorder

Approved drugs for the same conditions: Depression (major depressive disorder) · Bipolar disorder · Psychiatry

Largest trials

Live from ClinicalTrials.gov: studies naming "Icalcaprant" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 0 on PubMed

No PubMed records name it yet, which is common for early code-named drugs.

Also in development for Bipolar I Disorder

  • AzetukalnerXEN1101Phase 39 trials

    Xenon Pharmaceuticals Inc. · Focal Onset Seizures, Major Depressive Disorder, Bipolar Disorder

  • NBI-1117568Phase 35 trials

    Neurocrine Biosciences · Schizophrenia, Bipolar I Disorder, Mania

  • LB-102Phase 34 trials

    LB Pharmaceuticals Inc. · Schizophrenia, Bipolar I Disorder

  • OLZSAM, ALKS 3831Phase 32 trials

    Alkermes, Inc. · Bipolar I Disorder, Schizophrenia

  • ABBV-932Phase 23 trials

    AbbVie · Bipolar I or II Disorder, Generalized Anxiety Disorder (GAD), Bipolar I Disorder

  • AL-001lithium salicylate, L-proline cocrystalPhase 23 trials

    Beijing Anlong Biopharmaceutical Co., Ltd. · Wet Age-related Macular Degeneration (wAMD), Bipolar I Disorder

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from AbbVie.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.